On a sunny weekday in Atlanta, a small crowd of people gathered for a rally outside of a labor union headquarters building. The event, put together by Atlanta-area Democratic U.S. Rep. Nikema Williams, was attended mostly by union members and recently fired federal workers, including Ryan Sloane. “I was fired by an anonymous email at…
BOULDER, Colo. — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms can be ingested under supervision, in late spring or early summer. The dawn of state-regulated psychedelic mushrooms has arrived in Colorado, nearly two years since Oregon began offering them. The…
Tanay Tandon is CEO of Commure, which is essentially a startup conglomerate which includes the original Commure, Tanay’s company Athelas, ambient scribe Augmedix, the Strongline staff safety product, Memora Health’s workflows and more. HCA, the big for-profit chain, is one of the biggest customers and an investor in Commure. I grabbed Tanay at HIMSS earlier…
Our mental health system is not designed to treat people in crisis. Instead of being administered right away and effectively, it shoves patients through a maze of barriers. If we are serious about saving lives, then we must reconsider how mental health care is administered. The post The Mental Health Crisis: Why Immediate and Affordable…
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins. The post How Are Hospitals Faring Financially in 2025? appeared first on MedCity News.
An expanded partnership with Humana will help Aledade’s FQHC and rural health clinic partners share savings in Medicare Advantage. The post Aledade, Humana Expand Value-Based Partnership to Support FQHCs and Rural Health Clinics appeared first on MedCity News.
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals’ Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare…
Creating adequate capacity for any therapeutic can be challenging, and the specialized technologies for manufacturing complex biologics require flexibility and agility in production processes. Here’s how contract development and manufacturing organizations (CDMOs) ensure that biopharmaceutical companies have a partner with the speed, flexibility, and expertise necessary for successful drug development and manufacturing. The post Evolving…
State, federal, and academic initiatives have poured time and resources into understanding and addressing these gaps. So why haven’t we made real, lasting progress? The post The Broken Approach to Health Disparities appeared first on MedCity News.
KFF Health News editor-at-large for public health Céline Gounder discussed bird flu on CBS’ “CBS Mornings Plus” on March 20. Gounder discussed funding cuts at Johns Hopkins University and other research institutions on CBS News’ “CBS Morning News” on March 17. She also discussed the Centers for Disease Control and Prevention’s airplane wastewater testing to…